Tag: malignant pleural mesothelioma

Ikena Oncology gets FDA fast track designation for IK-930 in mesothelioma

pallavi123- June 23, 2022

Ikena Oncology has secured fast track designation for IK-930 from the US Food and Drug Administration in the treatment of unresectable NF2-deficient malignant pleural mesothelioma. ... Read More

Targovax gets FDA fast track status for ONCOS-102 in malignant pleural mesothelioma

pharmanewsdaily- February 15, 2021

Targovax, a Norwegian immune-oncology company, said that its lead candidate ONCOS-102 has secured the fast track designation from the US Food and Drug Administration (FDA) ... Read More

FDA approves BMS’ Opdivo, Yervoy combo for malignant pleural mesothelioma

pharmanewsdaily- October 4, 2020

Bristol Myers Squibb (BMS) has secured approval for Opdivo (nivolumab) and Yervoy (ipilimumab) combination from the US Food and Drug Administration (FDA) for the first-line ... Read More